Efficacy of BMS-180194 against experimental cytomegalovirus infections in immunocompromised mice
- 31 March 1996
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 29 (2-3) , 233-241
- https://doi.org/10.1016/0166-3542(95)00901-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirusAntiviral Research, 1995
- Phosphonylmethoxyalkyl purine and pyrimidine derivatives for treatment of opportunistic cytomegalovirus and herpes simplex virus infections in murine AIDSAntiviral Research, 1991
- GanciclovirDrugs, 1990
- CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS).The Journal of Experimental Medicine, 1988
- Clinical Aspects of Cytomegalovirus RetinitisClinical Infectious Diseases, 1988
- Treatment of Cytomegalovirus Retinitis with Trisodium Phosphonoformate Hexahydrate (Foscarnet)The Journal of Infectious Diseases, 1988
- Pulmonary Complications of the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1984
- Death in the AIDS Patient: Role of CytomegalovirusNew England Journal of Medicine, 1983
- Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patientsAnnals of Neurology, 1983
- The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infectionsArchiv für die gesamte Virusforschung, 1979